These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 25575600)
21. [Clinical study of the month: ASTEROID: regression of coronary atherosclerosis with rosuvastatin at a maximal daily dose of 40 mg]. Scheen AJ Rev Med Liege; 2006 Apr; 61(4):267-72. PubMed ID: 16789616 [TBL] [Abstract][Full Text] [Related]
22. Rationale and design of RETAIN study: Rosuvastatin Effect on Telomere-telomerase system in Acute coronary syndrome patients undergoing percutaneous coronary Intervention. Zhuang XD; Liao LZ; Guo Y; Li Y; Liao XX; Hu X; Du ZM Int J Cardiol; 2015 Apr; 184():388-390. PubMed ID: 25745990 [No Abstract] [Full Text] [Related]
23. Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial. Briguori C; Madonna R; Zimarino M; Calabrò P; Quintavalle C; Salomone M; Condorelli G; De Caterina R Cardiovasc Drugs Ther; 2016 Oct; 30(5):465-472. PubMed ID: 27358173 [TBL] [Abstract][Full Text] [Related]
24. The Effect of Genetic Polymorphisms in SLCO2B1 on the Lipid-Lowering Efficacy of Rosuvastatin in Healthy Adults with Elevated Low-Density Lipoprotein. Kim TE; Shin D; Gu N; Jung BH; Kim J; Cho YM; Yu KS; Cho JY Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):195-201. PubMed ID: 28627804 [TBL] [Abstract][Full Text] [Related]
25. Can statins alter coronary plaque composition assessed by radiofrequency backscatter intravascular ultrasound? Samady H; McDaniel MC JACC Cardiovasc Interv; 2009 Jul; 2(7):697-700. PubMed ID: 19628195 [No Abstract] [Full Text] [Related]
26. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial). Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123 [TBL] [Abstract][Full Text] [Related]
28. Aggressive lipid-lowering therapy and regression of coronary atheroma. Ravnskov U; Sutter MC JAMA; 2004 Jul; 292(1):38; author reply 39-40. PubMed ID: 15238580 [No Abstract] [Full Text] [Related]
29. Aggressive lipid-lowering therapy and regression of coronary atheroma. Rajaram K JAMA; 2004 Jul; 292(1):39; author reply 39-40. PubMed ID: 15238582 [No Abstract] [Full Text] [Related]
30. Aggressive lipid-lowering therapy and regression of coronary atheroma. van der Harst P; van Gilst WH; Zijlstra F JAMA; 2004 Jul; 292(1):39; author reply 39-40. PubMed ID: 15238583 [No Abstract] [Full Text] [Related]
31. Effect of two intensive statin regimens on progression of coronary disease. Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316 [TBL] [Abstract][Full Text] [Related]
32. Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia. Canepa M; Artom N; Ameri P; Carbone F; Montecucco F; Ghigliotti G; Brunelli C; Dallegri F; Pende A; Pisciotta L Int J Cardiol; 2018 Mar; 255():215-220. PubMed ID: 29290422 [No Abstract] [Full Text] [Related]
33. Statins for the prevention of post-thrombotic syndrome in patients with deep vein thrombosis. Comment on San Norberto et al, p. 133 - 140. Stevenson A; Gándara E Vasa; 2016; 45(2):83-4. PubMed ID: 27058793 [No Abstract] [Full Text] [Related]
34. Study on the effect of different doses of rosuvastatin on ventricular remodeling in patients with acute coronary syndrome after emergency percutaneous coronary intervention. Guo J; Zhang WZ; Zhao Q; Wo JS; Cai SL Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4457-4463. PubMed ID: 29077146 [TBL] [Abstract][Full Text] [Related]
35. Statins and prevention of stent-related late adverse events. Uemura S Coron Artery Dis; 2014 Jun; 25(4):277-8. PubMed ID: 24710353 [No Abstract] [Full Text] [Related]
36. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM; JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939 [TBL] [Abstract][Full Text] [Related]
37. Statins and coronary artery disease: clinical evidence and future perspective. Biasucci LM; Stefanelli A; Biasillo G Minerva Cardioangiol; 2012 Apr; 60(2):147-56. PubMed ID: 22495163 [TBL] [Abstract][Full Text] [Related]